GFAP and Alzheimer disease: To our knowledge, this is the first report of associations between plasma GFAP and [18F]FDG PET in the Alzheimer’s continuum. Our findings suggest that higher astrocytic reactivity, probably in response to early AD pathological changes, is related to significantly higher glucose consumption.